Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

Rituximab can cause skin issues, but baricitinib may help improve them.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Modern treatments can effectively regrow hair and improve life for people with alopecia areata.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

The new artificial derma is better for skin regeneration and biocompatibility.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

PAON shows skin patterns due to genetic mosaicism.

α-MSH may help treat skin inflammation and fibrosis.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Basal-cell epitheliomas and the pilosebaceous tract share a unique keratin, distinguishing them from other skin areas.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Cutaneous epitheliotropic lymphoma in dogs is often misdiagnosed but can be treated with chemotherapy and alternative therapies.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Amelanotic melanocytes from hair follicles are immature and likely don't transfer melanosomes to keratinocytes.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.